These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

543 related items for PubMed ID: 19243976

  • 1. Association between C-reactive protein and biomarkers of bone and mineral metabolism in chronic hemodialysis patients: a cross-sectional study.
    Lee CT, Tsai YC, Ng HY, Su Y, Lee WC, Lee LC, Chiou TT, Liao SC, Hsu KT.
    J Ren Nutr; 2009 May; 19(3):220-7. PubMed ID: 19243976
    [Abstract] [Full Text] [Related]

  • 2. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
    Brandi L.
    Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
    [Abstract] [Full Text] [Related]

  • 3. Mineral metabolism parameters throughout chronic kidney disease stages 1-5--achievement of K/DOQI target ranges.
    Craver L, Marco MP, Martínez I, Rue M, Borràs M, Martín ML, Sarró F, Valdivielso JM, Fernández E.
    Nephrol Dial Transplant; 2007 Apr; 22(4):1171-6. PubMed ID: 17205962
    [Abstract] [Full Text] [Related]

  • 4. Application of NKF-K/DOQI Clinical Practice Guidelines for Bone Metabolism and Disease: changes of clinical practices and their effects on outcomes and quality standards in three haemodialysis units.
    Arenas MD, Alvarez-Ude F, Gil MT, Soriano A, Egea JJ, Millán I, Amoedo ML, Muray S, Carretón MA.
    Nephrol Dial Transplant; 2006 Jun; 21(6):1663-8. PubMed ID: 16464885
    [Abstract] [Full Text] [Related]

  • 5. Prevalence, clinical correlates and therapy cost of mineral abnormalities among haemodialysis patients: a cross-sectional multicentre study.
    Lorenzo V, Martin-Malo A, Perez-Garcia R, Torregrosa JV, Vega N, de Francisco AL, Cases A.
    Nephrol Dial Transplant; 2006 Feb; 21(2):459-65. PubMed ID: 16263739
    [Abstract] [Full Text] [Related]

  • 6. Assessment of phosphorus and calcium metabolism and its clinical management in hemodialysis patients in the community of Valencia.
    Maduell F, Gorriz JL, Pallardo LM, Pons R, Santiago C, Multicentric group for the study of the phosphocalcic metabolism in the community of Valencia.
    J Nephrol; 2005 Feb; 18(6):739-48. PubMed ID: 16358233
    [Abstract] [Full Text] [Related]

  • 7. Effect of sevelamer on dyslipidemia and chronic inflammation in maintenance hemodialysis patients.
    Yamada K, Fujimoto S, Tokura T, Fukudome K, Ochiai H, Komatsu H, Sato Y, Hara S, Eto T.
    Ren Fail; 2005 Feb; 27(4):361-5. PubMed ID: 16060120
    [Abstract] [Full Text] [Related]

  • 8. Comparison between different dialysate calcium concentrations in nocturnal hemodialysis.
    Toussaint ND, Polkinghorne KR, Kerr PG, Somerville CA, Agar JW.
    Hemodial Int; 2007 Apr; 11(2):217-24. PubMed ID: 17403174
    [Abstract] [Full Text] [Related]

  • 9. Association of mineral metabolism with an increase in cellular adhesion molecules: another link to cardiovascular risk in maintenance haemodialysis?
    Arici M, Kahraman S, Gençtoy G, Altun B, Kalyoncu U, Oto A, Kirazli S, Erdem Y, Yasavul U, Turgan C.
    Nephrol Dial Transplant; 2006 Apr; 21(4):999-1005. PubMed ID: 16326734
    [Abstract] [Full Text] [Related]

  • 10. Neuropeptide Y and markers of osteoblast activity in dialysis patients: a cross-sectional study.
    Panuccio V, Cutrupi S, Pizzini P, Mallamaci F, Tripepi G, Zoccali C.
    Am J Kidney Dis; 2007 Dec; 50(6):1001-8. PubMed ID: 18037100
    [Abstract] [Full Text] [Related]

  • 11. Impact of the Kidney Disease Outcomes Quality Initiative (KDOQI) Clinical Practice Guidelines for Bone Metabolism and Disease in a large dialysis network.
    Wald R, Tentori F, Tighiouart H, Zager PG, Miskulin DC.
    Am J Kidney Dis; 2007 Feb; 49(2):257-66. PubMed ID: 17261428
    [Abstract] [Full Text] [Related]

  • 12. Serum triiodothyronine level as an indicator of inflammation in patients undergoing dialysis.
    Zeraati AA, Layegh P, Famili Y, Naghibi M, Sharifipour F, Shariati Sarabi Z.
    Iran J Kidney Dis; 2011 Jan; 5(1):38-44. PubMed ID: 21189433
    [Abstract] [Full Text] [Related]

  • 13. Level of high-sensitivity C-reactive protein in Saudi patients with chronic stable coronary artery disease.
    Habib SS.
    J Ayub Med Coll Abbottabad; 2008 Jan; 20(2):3-6. PubMed ID: 19385446
    [Abstract] [Full Text] [Related]

  • 14. Implications of levels of serum mineral metabolism markers, albumin and C-reactive protein for treatment costs of patients on maintenance dialysis.
    Salonen T, Piirto J, Reina T, Saha H, Pasternack A.
    Nephron Clin Pract; 2007 Jan; 106(1):c17-23. PubMed ID: 17347578
    [Abstract] [Full Text] [Related]

  • 15. Are CSN and NKF-K/DOQI mineral metabolism guidelines for hemodialysis patients achievable? Results from a provincial renal program.
    Wazny LD, Raymond CB, Lesperance EM, Bernstein KN.
    CANNT J; 2008 Jan; 18(2):36-41, 44-50; quiz 42-3, 51-2. PubMed ID: 18669010
    [Abstract] [Full Text] [Related]

  • 16. [CA-P control in haemodialysis and K/DOQI guidelines].
    Rivera F, Sánchez de la Nieta MD, Echarri R, Anaya S, Carreño A, Vozmediano MC, Alcaide MP.
    Nefrologia; 2006 Jan; 26(3):351-7. PubMed ID: 16892824
    [Abstract] [Full Text] [Related]

  • 17. Impact of lowering dialysate calcium concentration on serum bone turnover markers in hemodialysis patients.
    Hamano T, Oseto S, Fujii N, Ito T, Katayama M, Horio M, Imai E, Hori M.
    Bone; 2005 May; 36(5):909-16. PubMed ID: 15794928
    [Abstract] [Full Text] [Related]

  • 18. The relationship between serum calcium and phosphate levels and cardiac valvular procedures in the hemodialysis population.
    Rubel JR, Milford EL.
    Am J Kidney Dis; 2003 Feb; 41(2):411-21. PubMed ID: 12552504
    [Abstract] [Full Text] [Related]

  • 19. Study on the relationship of serum fetuin-A concentration with aortic stiffness in patients on dialysis.
    Hermans MM, Brandenburg V, Ketteler M, Kooman JP, van der Sande FM, Gladziwa U, Rensma PL, Bartelet K, Konings CJ, Hoeks AP, Floege J, Leunissen KM.
    Nephrol Dial Transplant; 2006 May; 21(5):1293-9. PubMed ID: 16396973
    [Abstract] [Full Text] [Related]

  • 20. Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival.
    Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P.
    Am J Kidney Dis; 2009 Jun; 53(6):1024-33. PubMed ID: 19394732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 28.